Evidence map›Paper›PMID 37362635›Full record

ArticleMultimedia tools and applications2023

COVID-19 radiograph prognosis using a deep CResNeXt network.

Dhirendra P Yadav, Anand Singh Jalal, Ayush Goyal, Avdesh Mishra, Khem Uprety, Nirmal Guragai

Open access · bronzeAbstract read
In one paragraph

Article in Multimedia tools and applications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Dhirendra P YadavDepartment of Computer Engineering & Applications, G.L.A. University, Mathura, UP India.
Anand Singh JalalDepartment of Computer Engineering & Applications, G.L.A. University, Mathura, UP India.ORCID 0000-0002-7469-6608
Ayush GoyalDepartment of Electrical Engineering and Computer Science, Texas A&M University, Kingsville, TX USA.
Avdesh MishraDepartment of Electrical Engineering and Computer Science, Texas A&M University, Kingsville, TX USA.
Khem UpretyThe University of Tennessee Health Science Center, Memphis, TN USA.
Nirmal GuragaiDepartment of Cardiology, St. Joseph Regional Medical Center, Paterson, NJ USA.
GLA University · INTexas A&M University – Kingsville · USSt. Joseph Regional Medical Center · USUniversity of Tennessee Health Science Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 has caused an epidemic in the entire world and it is caused by the novel virus SARS-COV-2. In severe conditions, this virus can cause a critical lung infection or viral pneumonia. To administer the correct treatment to patients, COVID-19 testing is important for diagnosing and determining patients who are infected with COVID-19, as opposed to those infected with other bacterial or viral infections. In this paper, a CResNeXt chest radiograph COVID-19 prediction model is proposed using residual network architecture. The advantage of the proposed model is that it requires lesser free hyper-parameters as compared to other residual networks. In addition, the training time per epochs of the model is very less compared to VGG19, ResNet-50, ResNeXt. The proposed CResNeXt model's binary classification (COVID-19 versus No-Finding) accuracy is observed to be 98.63% and 99.99% and multi-class classification (COVID-19, Pneumonia, and No-Finding) accuracy is observed to be 97.42% and 99.27% on the original and augmented datasets, respectively.

Indexed as

Chest radiographsCoronavirus (COVID-19)Deep learningMachine learningRadiology images

Identifiers

PMID37362635
PMCPMC9993361
OpenAlexW4323544631

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.